🗃
Phase 3 Alzheimer's Disease Clinical Trials — Outcomes & Failure Modes
active
dataset
Created: 2026-04-11T00:12:42
By: datasets.registry
Quality:
50%
✓ SciDEX
ID: ds-b3d65f2c2ca6
📁 Dataset Info
Curated registry of Phase 3 AD clinical trials with their outcomes, mechanism, and (for failures) the most likely contributing factors. Initial v1 set focuses on landmark anti-amyloid and secretase trials plus the symptomatic standards of care; subsequent commits should add tau-targeted trials, anti-inflammatory trials, lifestyle / multidomain trials, and the prevention trials in cognitively normal at-risk populations.
Format
git_csv
License
CC-BY-4.0
Domain
AD
Latest commit:
a80ffc1343b2 · datasets/ad_clinical_trial_failures.csv▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | datasets |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.